Towarzystwo Funduszy Inwestycyjnych PZU SA’s Revolution Medicines RVMD Stock Holding History

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.9K	Buy	+320	New	+$46.7K	0.02%	433

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Towarzystwo Funduszy Inwestycyjnych PZU SA's RVMD Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA opened a new position in Revolution Medicines (RVMD) in Q2 2026: 320 shares worth $59.9K. The stake represents 0.02% of the portfolio and ranks #433 among its holdings.

404 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Towarzystwo Funduszy Inwestycyjnych PZU SA held 320 shares of Revolution Medicines worth $59.9K as of Q2 2026.
Revolution Medicines was a new Towarzystwo Funduszy Inwestycyjnych PZU SA position in Q2 2026.
Revolution Medicines made up 0.02% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #433 holding.
404 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.